The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

"Women coming off weight loss injections in midlife need to be particularly strategic about their approach," Rachael adds. "The hormonal shifts of midlife can reduce muscle protein synthesis by up to ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

As per sources, Mounjaro contains the active ingredient tirzepatide. Mounjaro is approved by the Food and Drug Administration ...

The launch of Eli Lilly’s weight-loss drug Mounjaro in India has sparked a wave of interest, with some doctors reportedly ...